Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

SNOMED International Maintains its Commitment to the Use of SNOMED CT through Broadened Implementation Approaches

SNOMED International
Posted on: 01 Dec 17

London, U.K., Dec. 01, 2017 (GLOBE NEWSWIRE) -- SNOMED International's continuing commitment to champion and shepherd global health information standards is a responsibility we faithfully serve in partnership with our 30 Members, 1600+  affiliates, and numerous stakeholders. For these groups, this relationship is structured through the use of jointly negotiated licensing agreements. Alongside these established relationships, there are instances where non-licensed users may receive SNOMED CT coded health record information, requiring a broadened approach to enable access.

For this reason, in 2015 SNOMED International created a SNOMED CT development license for use by HL7 International and associated working groups. The purpose of this was to provide global implementation guidance to support consistent, joint use of both standards, as applicable. Through this approach, SNOMED International also agreed to negotiate development licenses with any HL7 International affiliate located in non-member countries.

In this capacity, SNOMED International, recognizing that both Members and non-members may move information containing SNOMED CT codes, has required that some parameters of use be adhered to. In the event a non-licensed user receives SNOMED CT codes as part of a health data transfer, SNOMED International has deemed this within the definition of acceptable use. Further, in cases where non-licensed users frequently receive SNOMED CT coded information and engage in health record mapping, SNOMED International requests notification so that the organization may review use as well as confirm that the mapping is appropriate and quality assured. Not only does this process assist in ensuring that patient safety is maintained at the highest level, but also supports a universal, interoperable approach to health information exchange that limits divergence.

Currently there are a number of groups that are working on International Patient Summaries, as well as European Union cross border projects. At present SNOMED International is working with the European Commission to ensure a consistent approach with the licensing and use for these areas.

We anticipate that in early 2018 we will be in a position to further communicate our approach regarding these global initiatives.

All questions may be directed to

About SNOMED International:
SNOMED International is a not-for- profit organization that owns and develops SNOMED CT, the world's most comprehensive healthcare terminology product. We play an essential role in improving the health of humankind, by determining standards for a codified language thatrepresents groups of clinical terms. This enables healthcare information to be exchanged globally for the benefit of patients and other stakeholders. We are committed to the rigorous evolution of our products and services, to deliver continuous innovation for the global healthcare community. SNOMED International is the trading name of the International Health Terminology Standards Development Organisation. 

SNOMED CT is the world's most comprehensive healthcare terminology product. It enables the global exchange of medical information through a codified language that represents groups of clinical terms. SNOMED CT is rigorously evolved to meet the diverse, varying needs of clinicians and other stakeholders across different disciplines, sectors and geographies. The value to patients, healthcare providers, vendors and government departments is clear: precise, exchangeable medical data results in better health records, clinical decisions and data analysis, helping clinicians save time, money and lives.


A photo accompanying this announcement is available at

Kelly Kuru
SNOMED International
1 416 566 8725

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: SNOMED International via GlobeNewswire

Last updated on: 04/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.